[PDF][PDF] Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death

BR Logan, D Fu, A Howard, M Fei… - Journal of Clinical …, 2023 - Am Soc Clin Investig
BACKGROUND Chronic graft-versus-host disease (cGVHD) is a serious complication of
allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding …

[HTML][HTML] Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review

NR Neuendorff, A Khan, F Ullrich, S Yates… - Journal of Geriatric …, 2024 - Elsevier
Cellular therapies, including autologous stem cell transplant (ASCT), allogeneic
hematopoietic cell transplantation (alloHCT), and chimeric antigen receptor-(CAR-) T cell …

[HTML][HTML] Results of an innovative program for surveillance, prophylaxis, and treatment of infectious complications following allogeneic stem cell transplantation in …

M Malagola, A Turra, L Signorini, S Corbellini… - Frontiers in …, 2022 - frontiersin.org
Background. Infectious complications are a significant cause of morbidity and mortality in
patients undergoing allogeneic haematopoietic stem cell transplantation (Allo-SCT). The …

[HTML][HTML] Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting …

J Zhang, X Wang, R Wang, G Chen, J Wang, J Feng… - Biomedicines, 2023 - mdpi.com
In this study, we test the therapeutic effects of rapamycin in a murine model of SLE-like
experimental lupus nephritis induced by chronic graft-versus-host disease (cGVHD). Our …

[HTML][HTML] Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease

E Schulz, F Pirsl, NG Holtzman, D Beshensky… - …, 2024 - ncbi.nlm.nih.gov
Chronic graft-versus-host disease (cGvHD) is an important immunologic complication of
allogeneic hematopoietic cell transplantation (HCT) that can affect multiple organs and lead …

Impact of Center Volume on Chronic Graft Versus Host Disease in Patients With Allogeneic Stem Cell Transplantation

Y Shimomura, T Kitamura, M Murata, K Matsuo… - … and Cellular Therapy, 2024 - Elsevier
Chronic graft-versus-host disease (cGVHD) is a complication of allogeneic hematopoietic
stem cell transplantation (HSCT), negatively impacting quality of life (QoL) and increasing …

Rational use of chronic graft-versus-host treatment alternatives: A systematic review

M Yeral, C Boğa - Transfusion and Apheresis Science, 2022 - Elsevier
Chronic graft versus host disease (cGVHD) is an important transplant complication that
affects the quality of life of the recipient by causing organ damage after hematopoietic stem …

Dynamic forecasting module for chronic graft-versus-host disease progression based on a disease-specific subpopulation of B cells

A Xiang, Y Ma, J Chen, Z Fan, J Shi, G Li, X Li, T Wang… - 2024 - researchsquare.com
Due to its dynamic nature and the absence of reliable real-time monitoring tools, predicting
chronic graft-versus-host disease (cGVHD) progression was challenging. This caused a …

[引用][C] Advancements in the Management of Chronic Graft-versus-Host Disease

C Cutler, D Miklos, EK Waller